Clicks Group Ltd CLS

Morningstar Rating
ZAC 39,767.00 +288.00 (0.73%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CLS is trading within a range we consider fairly valued.
Price
ZAR 397.32
Fair Value
ZAR 519.98
Uncertainty
High
1-Star Price
ZAR 122.54
5-Star Price
ZAR 438.90
Economic Moat
Rxb
Capital Allocation

Trading Information

Previous Close Price
ZAC 39,479.00
Day Range
ZAC 39,161.0039,821.00
52-Week Range
ZAC 23,556.0040,015.00
Bid/Ask
ZAC 38,507.00 / ZAC 40,400.00
Market Cap
ZAC 9.47 Tril
Volume/Avg
800,733 / 699,059

Key Statistics

Price/Earnings (Normalized)
36.03
Price/Sales
2.21
Dividend Yield (Trailing)
1.77%
Dividend Yield (Forward)
1.77%
Total Yield
3.40%

Company Profile

Clicks Group Ltd operates pharmaceutical health and beauty retail stores. The company primarily operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company targets middle- to upper-income consumers. Clicks' business strategy focuses on consistent product sourcing, product development, and measured store expansion. The company has a portfolio of retail franchise brands including The Body Shop, GNC, and claire's. Clicks uses United Pharmaceutical Distributors' capabilities for the groups' integrated channel to the healthcare market.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Mid Growth
Total Number of Employees
18,741

Comparables

Valuation

Metric
CLS
DCP
MRP
Price/Earnings (Normalized)
36.0332.3820.92
Price/Book Value
18.087.374.80
Price/Sales
2.210.901.92
Price/Cash Flow
21.8215.8211.24
Price/Earnings
CLS
DCP
MRP

Financial Strength

Metric
CLS
DCP
MRP
Quick Ratio
0.310.390.75
Current Ratio
1.031.191.74
Interest Coverage
13.373.915.55
Quick Ratio
CLS
DCP
MRP

Profitability

Metric
CLS
DCP
MRP
Return on Assets (Normalized)
14.51%5.95%11.31%
Return on Equity (Normalized)
47.21%23.64%24.51%
Return on Invested Capital (Normalized)
31.07%13.88%13.52%
Return on Assets
CLS
DCP
MRP

Pharmaceutical Retailers Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Alibaba Health Information Technology Ltd
ALBHF
Qcdtlg$8.5 Bil
Alibaba Health Information Technology Ltd ADR
ALBBY
Zrldsc$8.5 Bil
Raia Drogasil SA ADR
RADLY
Ylfhrtb$8.1 Bil
Walgreens Boots Alliance Inc
WBA
WjfXnlms$7.8 Bil
Clicks Group Ltd ADR
CLCGY
Grfxx$5.5 Bil
COSMOS Pharmaceutical Corp
CSMYF
Gxlds$4.0 Bil
Tsuruha Holdings Inc
TSUSF
Qtdsc$3.1 Bil
Redcare Pharmacy NV ADR
SAEYY
Vzytfg$3.0 Bil
DocMorris AG
ZRSEF
Nhqz$572.0 Mil
High Tide Inc
HITI
Qyzh$162.8 Mil

Sponsor Center